Navigation Links
Cell Therapeutics, Inc. (CTI) to Present at 2009 BIO International Convention
Date:5/13/2009

SEATTLE, May 14 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) management will present at the 2009 BIO International Convention at the Georgia International Convention Center in Atlanta, Georgia, on Tuesday, May 19th at 10:40 AM in Room 311 of Building A, Level 3.

                          2009 BIO International Convention
                       CTI Presentation: Tuesday, May 19, 2009
               10:40 AM Eastern/4:40 PM Central European/7:40 AM Pacific
                       Georgia International Convention Center
                            Room 311, Building A, Level 3



    Media Contact:                          Investors Contact:
    Cell Therapeutics, Inc.                 Cell Therapeutics, Inc.
    Dan Eramian                             Ed Bell
    T: 206.272.4343                         T: 206.272.4345
    F: 206.272.4434                         Lindsey Jesch Logan
    E: media@ctiseattle.com                 T: 206.272.4347
    www.celltherapeutics.com/press_room     F: 206.272.4434
                                            E: invest@ctiseattle.com
                                            www.celltherapeutics.com/investors

Available Topic Experts: For information on the listed experts, click appropriate link.

Jack W. Singer, M.D.

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=60728

James A. Bianco, M.D.

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=60729


'/>"/>
SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
2. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
3. ARYx Therapeutics, Inc. Files Registration Statement for Initial Public Offering
4. Nile Therapeutics, Inc. Adds to Executive Management Team
5. Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer
6. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
7. Cell Therapeutics, Inc. (CTI) Announces 2007 Annual Shareholders Meeting Results
8. Northwest Biotherapeutics, Inc. Announces Appointment of Chief Financial Officer
9. Nile Therapeutics, Inc. to Present at Upcoming BIO Investor Forum
10. Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event
11. Cell Therapeutics, Inc. (CTI) BIO Presentation to Be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... ... , ... Over 8,000 recognized rare diseases afflict an estimated 350 million people ... March 7, DrugDev will gather international experts to share challenges and provide insight and ... Overcoming the Challenges of Rare Disease Clinical Trials, Date: March 7, 2017, Time: 10:00-11:00 ...
(Date:2/28/2017)... , ... February 28, 2017 , ... ... discovery of antibody therapeutics from millions-diverse immune repertoires, today announced a strategic partnership ... mouse strains genetically engineered to express human antibodies. The partnership will use GigaGen ...
(Date:2/28/2017)... PHILADELPHIA , Feb. 28, 2017 ... company focusing on debilitating diseases including rare genetic diseases ... the company joins with the National Organization for Rare ... support around the world in commemorating Rare Disease Day, ... and needs of the millions of patients and families ...
(Date:2/28/2017)... VANCOUVER , Feb. 28, 2017 /PRNewswire/ - RepliCel ... "Company"), a clinical stage regenerative medicine company developing unique ... and sun-damaged skin, and chronic tendon degeneration, today announced ... both of whom have committed to work with RepliCel ... manufactured and tested. ...
Breaking Biology Technology:
(Date:2/1/2017)... , February 1, 2017 IDTechEx Research, a ... emerging technology, announces the availability of a new report, Sensors ... Continue Reading ... ... and collaborative robots. Source: IDTechEx Report "Sensors for Robotics: Technologies, Markets ...
(Date:1/30/2017)... --  Invitae Corporation (NYSE: NVTA ), ... announced that it will report its fourth quarter and ... Monday, February 13, 2017, and Invitae,s management team will ... Eastern / 1:45 p.m. Pacific. During ... results, guidance, and recent developments and will spend the ...
(Date:1/26/2017)... Jan. 26, 2017  Acuity Market Intelligence today ... and Digital Identity".  Acuity characterizes 2017 as a ... increased adoption reflects a new understanding of the ... "Biometrics and digital identity are often perceived as ... Most , Principal of Acuity Market intelligence. "However, ...
Breaking Biology News(10 mins):